{"data":[{"accessionNo":"0001037389-26-000047","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":"097702203","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-06-24","reportingPerson":"Renaissance Technologies Holdings Corporation","reportingCik":null,"personType":"HC","sharesOwned":98625,"percentOfClass":5.13,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001037389-26-000047","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":"097702203","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-06-24","reportingPerson":"Renaissance Technologies LLC","reportingCik":null,"personType":"IA","sharesOwned":98625,"percentOfClass":5.13,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"NF Investment Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":87486,"percentOfClass":4.6,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Nan Fung Group Holdings Limited","reportingCik":"0001782539","personType":"CO","sharesOwned":87486,"percentOfClass":4.6,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Nan Fung Life Sciences Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":82486,"percentOfClass":4.3,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Pivotal bioVenture Partners Fund I, L.P.","reportingCik":"0001695076","personType":"PN","sharesOwned":52556,"percentOfClass":2.7,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Pivotal bioVenture Partners Fund I G.P., L.P.","reportingCik":"0001752862","personType":"PN","sharesOwned":52556,"percentOfClass":2.7,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Pivotal bioVenture Partners Fund I U.G.P. Ltd.","reportingCik":null,"personType":"CO","sharesOwned":52556,"percentOfClass":2.7,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Pivotal Partners Ltd","reportingCik":null,"personType":"CO","sharesOwned":52556,"percentOfClass":2.7,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Pivotal Life Sciences Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":52556,"percentOfClass":2.7,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"NFLS Beta Limited","reportingCik":null,"personType":"CO","sharesOwned":29930,"percentOfClass":1.6,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"NFLS Platform Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":29930,"percentOfClass":1.6,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000212","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-24","reportingPerson":"Permwell Management Limited","reportingCik":null,"personType":"CO","sharesOwned":5000,"percentOfClass":0.3,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Nan Fung Group Holdings Limited","reportingCik":"0001782539","personType":"CO","sharesOwned":128119,"percentOfClass":6.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"NF Investment Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":128119,"percentOfClass":6.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Nan Fung Life Sciences Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":123119,"percentOfClass":6.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Pivotal bioVenture Partners Fund I, L.P.","reportingCik":"0001695076","personType":"PN","sharesOwned":78445,"percentOfClass":4.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Pivotal bioVenture Partners Fund I G.P., L.P.","reportingCik":"0001752862","personType":"PN","sharesOwned":78445,"percentOfClass":4.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Pivotal bioVenture Partners Fund I U.G.P. Ltd.","reportingCik":null,"personType":"CO","sharesOwned":78445,"percentOfClass":4.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Pivotal Partners Ltd","reportingCik":null,"personType":"CO","sharesOwned":78445,"percentOfClass":4.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Pivotal Life Sciences Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":78445,"percentOfClass":4.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"NFLS Beta Limited","reportingCik":null,"personType":"CO","sharesOwned":44674,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"NFLS Platform Holdings Limited","reportingCik":null,"personType":"CO","sharesOwned":44674,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001012975-26-000173","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-02-05","reportingPerson":"Permwell Management Limited","reportingCik":null,"personType":"CO","sharesOwned":5000,"percentOfClass":0.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001213900-26-016669","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vivo Panda, LLC","reportingCik":null,"personType":"OO","sharesOwned":72414,"percentOfClass":3.8,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001213900-26-016669","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vivo Panda Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":72414,"percentOfClass":3.8,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001213900-26-016669","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vivo Capital VIII, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001213900-26-016669","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vivo Capital Fund VIII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001213900-26-016669","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vivo Capital Surplus Fund VIII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":66879,"percentOfClass":3.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":66879,"percentOfClass":3.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":66879,"percentOfClass":3.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":66879,"percentOfClass":3.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":37675,"percentOfClass":2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":37675,"percentOfClass":2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":29204,"percentOfClass":1.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":29204,"percentOfClass":1.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016687","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"},{"accessionNo":"0001214659-25-016680","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001641281","issuerName":"Bolt Biotherapeutics, Inc.","ticker":"BOLT","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bolt"}],"updatedAt":"2026-11-03T22:32:00.894Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bolt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}